Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LINCOMYCIN vs LIPEGFILGRASTIM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LINCOMYCIN vs LIPEGFILGRASTIM: Safety Overview

Metric LINCOMYCIN LIPEGFILGRASTIM
Total FAERS Reports 210 425
Deaths Reported 21 41
Death Rate 10.0% 9.6%
Hospitalizations 37 248
Average Patient Age 46.3 yrs 56.4 yrs
% Female Patients 69.3% 50.0%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Pharmacia & Upjohn Company LLC N/A
Route INTRAMUSCULAR N/A
Marketing Status Discontinued N/A